Farnesoid X receptor agonism – a new approach to the treatment of cholesterol gallstone disease

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 4, 2005-04 ,pp. : 535-538

Informa Healthcare

Access to resources Recommend Favorite

Modulation of Cholesterol Crystallization in Bile. Implications for Non- Surgical Treatment of Cholesterol Gallstone Disease

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 2, 2005-06 ,pp. : 177-184

Bentham Science Publishers

Access to resources Recommend Favorite

Pathobiology of Cholesterol Gallstone Disease: From Equilibrium Ternary Phase Diagram to Agents Preventing Cholesterol Crystallization and Stone Formation

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 1, 2003-03 ,pp. : 67-81

Bentham Science Publishers

Access to resources Recommend Favorite

Limits and perspective of oral therapy with statins and aspirin for the prevention of symptomatic cholesterol gallstone disease

By Cariati Andrea   Piromalli Elisa  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1223-1227

Informa Healthcare

Access to resources Recommend Favorite

Nuclear Receptors as Potential Molecular Targets in Cholesterol Accumulation Conditions: Insights from Evidence on Hepatic Cholesterol Degradation and Gallstone Disease in Humans

By  

Current Medicinal Chemistry, Vol. 15, Iss. 22, 2008-09 ,pp. : 2271-2284

Bentham Science Publishers

Access to resources Recommend Favorite